Inovio Receives NIH Funding to Target its dMAb(R) Technology A...
PLYMOUTH MEETING, Pennsylvania, Sept. 17, 2019 /PRNewswire-AsiaNet/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that the company and its collaborator The Wistar Institute have received a $4.6 million National Institutes of Health (NIH) grant in support of innovative research to tackle antimicrobial ...
Authors: LATEST ASIANET NEWS RELEASES